It will be used in schools and public places. Corona symptom detection device using machine learning.
The Tiger Tech Coved Plus screen is designed for use by trainers, to help prevent exposure to and spread of the Corona virus.
The U.S. Food and Drug Administration (FDA) has issued a permit to use the first emergency screening device for CORONA virus, which is based on machine learning and identifies some biomarkers that indicate certain types of conditions.
The ready is called Tiger Tech COVID Plus Monitor, an arm band that uses light sensors and a small computer processor to check for virus biomarkers, such as hypercoagulation (a common coronavirus abnormality that causes blood clotting more easily).
The Tiger Tech Coved Plus screen is designed for use by trainers, to help prevent exposure to the Coved-19 virus and its spread.
The device identifies some biomarkers that may indicate hiv infection, as well as other hypercoagulants such as sepsis or cancer, or cases of excessive inflammation such as severe allergic reactions in individuals without symptoms.
The AI-based screening device is the latest tool to obtain authorization from the U.S. Food and Drug Administration and is designed to identify the underlying signs of MERS-CoV in people without symptoms.
After connecting the device to a person’s arm, the sensors start collecting pulse signals from blood flow over a period of 3 to 5 minutes, and then the processor extracts the basic information from the measurements and feeds them through the machine learning model.
The final results are represented by different color lights, including whether the test shows positive biomarkers, such as hypercoagulation or inconclusive biomarkers.
In its announcement, the U.S. Food and Drug Administration highlighted that the arm bar should not be a substitute for regular testing, nor is it designed to use people with symptoms.
Instead, it is intended to serve as a backup support along with a temperature check if reading does not indicate fever in individuals with no symptoms.
The two screening tools could be used together to reduce the spread of the virus in a range of public places, including health care facilities, schools, workplaces, parks, stadiums and airports, the agency said.
« The FDA is committed to continuing to support innovative methods of controlling the Corona pandemic through new screening tools, » said Jeff Schorin, director of the FDA’s Center for Devices and Radiation Health.
« The combination of the use of this new screening device, which can indicate some biomarkers, with temperature tests, can help identify individuals who may be infected with the virus, thus helping to reduce the spread of the virus in a variety of public places, including health care facilities, schools, workplaces, parks, stadiums and airports, » he said.
The announcement of the device’s work follows clinical studies in hospitals and schools that have shown similar results.
In the hospital environment, the device correctly detected the virus’s biomarkers at a rate of 98.6%, with a precise identification of those cases that do not have 94.5% warning signs, as confirmed by the school trial, according to the Food and Drug Administration.